- Home
- ACIU vs VOXR Comparison
ACIU vs VOXR Comparison
Compare ACIU & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- VOXR
- Stock Information
- Founded
- ACIU 2003
- VOXR 2014
- Country
- ACIU Switzerland
- VOXR United States
- Employees
- ACIU N/A
- VOXR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- VOXR Precious Metals
- Sector
- ACIU Health Care
- VOXR Basic Materials
- Exchange
- ACIU Nasdaq
- VOXR Nasdaq
- Market Cap
- ACIU 168.7M
- VOXR 168.0M
- IPO Year
- ACIU 2016
- VOXR N/A
- Fundamental
- Price
- ACIU $1.73
- VOXR $3.52
- Analyst Decision
- ACIU Strong Buy
- VOXR
- Analyst Count
- ACIU 2
- VOXR 0
- Target Price
- ACIU $10.00
- VOXR N/A
- AVG Volume (30 Days)
- ACIU 103.2K
- VOXR 277.2K
- Earning Date
- ACIU 08-05-2025
- VOXR 05-15-2025
- Dividend Yield
- ACIU N/A
- VOXR 1.45%
- EPS Growth
- ACIU N/A
- VOXR N/A
- EPS
- ACIU N/A
- VOXR N/A
- Revenue
- ACIU $32,014,254.00
- VOXR $10,845,445.00
- Revenue This Year
- ACIU N/A
- VOXR $16.51
- Revenue Next Year
- ACIU $533.21
- VOXR $4.60
- P/E Ratio
- ACIU N/A
- VOXR N/A
- Revenue Growth
- ACIU 91.20
- VOXR N/A
- 52 Week Low
- ACIU $1.43
- VOXR $2.16
- 52 Week High
- ACIU $4.98
- VOXR $3.79
- Technical
- Relative Strength Index (RSI)
- ACIU 54.55
- VOXR 57.21
- Support Level
- ACIU $1.60
- VOXR $3.26
- Resistance Level
- ACIU $1.82
- VOXR $3.77
- Average True Range (ATR)
- ACIU 0.10
- VOXR 0.19
- MACD
- ACIU 0.01
- VOXR 0.00
- Stochastic Oscillator
- ACIU 65.38
- VOXR 49.53
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.